Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 138,023 $ 21,398
Accounts receivable 75 48
Accounts receivable due from related parties 2,668 1,333
Prepaid expenses and other current assets 2,837 1,964
Total current assets 143,603 24,743
Property, plant and equipment, net 25,216 10,993
Deferred engineering costs 9,000 0
Goodwill 1,190 1,190
Note receivable due from related party 0 251
Other non-current assets 11,213 1,901
Total assets 190,222 39,078
Current liabilities:    
Accounts payable and accrued liabilities 27,189 24,403
Accounts payable due to related parties 323 323
Total current liabilities 27,512 24,726
Embedded derivative 0 8,753
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Common stock: par value $0.01 and $0.001 per share, respectively; 400 million shares and 200 million shares authorized, respectively; 214.0 million shares and 109.6 million shares issued, respectively 1,943 101
Treasury stock: 1.3 million and zero shares, respectively, at cost (828) 0
Additional paid-in capital 454,986 102,148
Accumulated deficit (293,391) (96,655)
Total stockholders’ equity 162,710 5,599
Total liabilities and stockholders’ equity 190,222 39,078
Series A Preferred Stock    
Stockholders’ equity:    
Series A convertible preferred stock: par value $0.001 per share; zero and 5.5 million shares authorized and issued, respectively $ 0 $ 5